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summARy – The increasing number of possible recipients for kidney transplantation and re-
latively unchanged number of organ donors has led to consideration of alternative strategies and ex-
pansion of deceased donor criteria in order to expand donor pool. previously, kidneys from expanded 
criteria donors (eCd) were strongly underestimated because of the conventional opinion suggesting 
these kidneys to have a higher rate of preservation injury, delayed graft function, rejection and 
nonfunction. Reducing the difference between graft outcome in patients transplanted from eCd 
and standard criteria donor (sCd) is one of the goals of many respectable kidney transplantation 
centers. This assignment includes major concern about reduction of cold ischemia time, recipient 
selection, novel and adapted immunosuppressive regimens, increased nephron mass by dual kid-
ney transplantation, and using histologic criteria for marginal donor graft selection. There are not 
many reports on the outcome of kidneys transplanted from donors with acute renal failure and high 
terminal creatinine. This review presents the exact definition of marginal donor, especially donor 
with acute renal failure. The management of such grafts during preimplantation and implantation 
period, outcomes and post-transplantation care are the main assignments for transplantation teams. 
Recipients of such grafts should be well informed about the possibilities and potential complications 
and sign their informed consent thereafter. some respectable studies have shown that under certain, 
highly controlled conditions, these kidneys can be used safely, with excellent short- and long-term 
outcomes. 
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Introduction
Kidney transplantation is the treatment of choice 
for all patients with end-stage renal disease (esRd), 
without contraindications for immunosuppressive 
treatment, while it offers better quality of life and 
better survival when compared with dialysis1,2. The 
increasing number of potential renal transplant recipi-
ents on waiting lists is not followed by appropriate rise 
in the number of deceased donors. This discrepancy 
challenges transplantation centers to consider other 
opportunites for making more organs available for 
transplantation. in order to expand donor pool, many 
centers have started to use kidneys from older and ex-
panded criteria donors (eCd).
until 2002, transplant centers used intuition to 
discriminate organs that were supposed to have less 
than optimal function3. Based on the ‘clinical feel-
ing’ of transplantation teams, most of the kidneys 
supposed to have poor graft outcome were discarded. 
Thus, donors at advanced age, impaired hemodynam-
ics and prolonged ischemia time, as well as donors 
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with elevated serum creatinine level prior to trans-
plantation were refused.
in 2002, port et al. defined eCd as a deceased 
donor aged 60 years or older, or donor aged 50 to 59, 
with minimum 2 factors: history of hypertension, se-
rum creatinine level greater than 1.5 mg/dl (132.6 
mmol/l) and cerebrovascular cause of death. The risk 
of graft failure in these transplantations was much 
higher than for grafts from standard criteria donors 
(sCd). using Cox regression models, port et al. dem-
onstrated a 70% higher risk of graft failure compared 
to ideal kidneys (relative risk greater than 1.7). Ac-
cording to their study, grafts from older donors with 
diabetes, hypertension or renal impairment have a 
higher risk of failure but are good enough to be trans-
planted4. however, based on the eCd graft defini-
tion, the first assumption is an increased risk of a less 
favorable outcome compared to sCd graft. in this 
way, refusals of eCd kidneys are frequent and cold 
ischemia time is prolonged, leading to organ discard-
ing5. massie et al. report that many transplant centers 
express their villingness to accept eCd transplants, 
but finally refuse organs when they are offered, thus 
creating delays that result in organ discarding6. 
As there is no unique definition of appropriate 
kidney graft, transplantation centers differ according 
to the criteria for refusal or acceptance of grafts con-
sidered to be marginal. The most common reason for 
refusal is hemodynamically unstable donor and high 
terminal serum creatinine. nevertheless, the use of 
eCd has led to an increased number of transplanted 
patients with better survival compared to patients on 
dialysis2. A new target of modern kidney transplanta-
tion is to reduce the difference between the outcomes 
of recipients who received allograft from marginal 
donors and recipients transplanted from optimal do-
nors.
in this review, we discuss the issue of eCd and 
define the strategies to improve the outcome of kid-
neys obtained from these donors.
Donor with Acute Kidney Injury
Acute kidney injury (AKi) represents rapid dete-
rioration of kidney function that occurs in approxi-
mately 5% of all hospitalized patients. it is one of the 
most common complications in intensive care units 
(iCu) affecting 36% of these patients7. in more than 
50% of AKi in iCu, the cause of kidney injury is sep-
tic shock or sepsis.
The causes of AKi in hospitalized patients with-
out previous kidney disease can be prerenal, renal and 
postrenal. in 60%-70% of cases, the cause is prerenal, 
including dehydration, hypoperfusion, ischemia due 
to blood loss, sepsis, surgery, severe burn and injury, 
liver or heart failure. Renal damage is the most com-
plicated cause of AKi, which affects filtering func-
tion or blood supply within the kidney or kidney tis-
sue responsible for salt and water balance. infections 
cause glomerulonephritis. A common cause of acute 
interstitial nephritis are nephrotoxic agents, including 
drug abuse such as heroin and cocaine, crush injuries 
leading to myoglobinuria, and drugs frequently used 
in iCu at inappropriate doses such as antibiotics, anti-
inflammatory drugs, and diuretics. Acute interstitial 
nephritis is usually reversible if kidney damage is not 
severe. Acute tubular necrosis is usually the result of 
other causes of renal damage accounting for 90% of 
primary renal AKi cases. postrenal failure is a rare 
cause of acute kidney failure in iCu8,9.
in iCu patients with AKi who are considered as 
potential kidney donors, we are searching for correct-
able causes of AKi in order to optimize kidney func-
tion and prepare them for potential grafting. interpre-
tation of kidney injury is a problem when evaluating 
potential donors. in some patients admitted to iCu, 
AKi is nothing but acutization of chronic renal failure. 
some patients admitted with a good kidney function 
experience rapid deterioration of kidney function due 
to numerous reasons. As mentioned above, common 
reasons of renal failure in iCu are prerenal and renal. 
Radiocontrast induced kidney injury is usually a re-
versible form of AKi, defined as an increase of serum 
creatinine level by more than 25% or its absolute in-
crease of 0.5 mg/dl early after radiographic examina-
tion using radiocontrast agent. A common question is 
how to quantify damage in donors to discriminate the 
potential grafts with good outcome. A problem is that 
most studies investigating outcome of kidney trans-
plantation from donors with high terminal creatinine 
are based on the last serum creatinine level rather than 
its change during intensive care management. 
serum creatinine is a widely used parameter for 
calculating glomerular filtration rate (gfR) in ev-
eryday practice, but its sensitivity and specificity in 
Acta Clin Croat,  Vol. 52,  No. 2,  2013 225
iva Bačak Kocman et al. Kidney transplantation from deceased donors with high terminal serum creatinine
predicting AKi are unknown. As a sole parameter, 
serum creatinine is a poor predictor of kidney damage 
because of rapidly changing levels in critically ill pa-
tients with AKi and its dependence on muscle mass. 
in recent studies, there is a question of predicting the 
reversibility of kidney damage, and impact of AKi on 
long-term graft survival, graft function and rejection. 
some studies show that high serum creatinine solely 
cannot be a measure to discard kidney for transplanta-
tion. Reduction of serum creatinine level in donors is 
not a sign of insult recovery, although high serum cre-
atinine level does not represent irreversible injury10.
The risk, injury, failure, loss and end-stage renal 
disease (Rifle) criteria are internationally accepted 
classification for kidney damage in AKi in hospital-
ized patients. in 2010, Rodrigo et al. first reported the 
use of Rifle criteria to evaluate AKi in deceased 
donors. The idea of the study was to standardize and 
quantify renal injury in donors and the possible influ-
ence on graft outcome. Risk was defined as creatinine 
increase x1.5, injury as x2 and failure as the last creati-
nine increase x3 with respect to its value on admission 
day. The authors of the study conclude that Rifle 
criteria are feasible in the diagnosis of AKi in kidney 
donors, but further studies including a larger number 
of patients are needed to confirm this hypothesis11. 
however, this classification cannot be used as isolated 
criteria for discarding donated kidney. 
in 2006, Kumar et al. reported three-year results 
of successful kidney transplantation from deceased 
donor with AKi, but the authors did not use Rifle 
criteria to classify AKi. This study reported compa-
rable three-year kidney function between the kidneys 
transplanted from selected deceased donors with acute 
renal failure without previous positive medical history, 
chronic histologic lesions, and kidneys from sCd12.
Quality of Kidney Grafts – Objective Measures 
and Donor Selection 
in 2006, Remuzzi et al. assesed outcome of renal 
transplantation from older donors. it was well known 
from clinical practice that long-term survival of re-
nal grafts obtained from elderly donors is inferior to 
survival of grafts from younger donors. however, Re-
muzzi et al. wanted to prove that selection of older 
kidneys according to histologic characteristics before 
transplantation could influence graft outcome. An 
international group of pathologists presented a scor-
ing system for kidneys from donors older than 60, 
based on biopsy findings. The intention was assess-
ment of kidneys with enough viable nephrons, avail-
able for transplantation by thorough analysis of the 
tubuli, vessels, glomeruli and internal changes. scores 
ranged from 0 (absence of lesions) to a maximum of 
12 (marked changes in renal parenchyma). Kidneys 
with scores 3 or lower were supposed to be used as a 
single transplants. Kidneys with scores 4, 5 or 6 could 
be used as dual transplants (only if the total number of 
viable nephrons in two kidneys approached the num-
ber in one ideal kidney). discarded were kidneys with 
score 7 or higher. The graft survival rate of histologi-
cally evaluated marginal kidneys did not differ from 
kidneys of donors under 60, but it was better than 
in recipients whose grafts from donors older than 60 
were not evaluated histologically. Remuzzi et al. con-
clude that histologic criteria have a critical role in the 
evaluation of marginal donors, as they are improving 
graft outcomes and in this way might expand the pool 
of donors. nowadays, many transplantation centers 
have implemented preimplantation kidney biopsy as a 
routine procedure in order to identify usable grafts13.
All kidney grafts, either from old or young, mar-
ginal or standard criteria donor could be harmed with 
some events just before donation or previously, even 
before the donor was admitted to iCu (chronic le-
sions). some potential donors may have high serum 
creatinine at the time of admission to iCu, as they 
have chronic renal insufficiency. serum creatinine 
level could rise a few days before donation because of 
several reasons related to stay or treatment in iCu. 
understandably, only grafts with acute, correctable 
renal dysfunction are considered for transplantation. 
Biopsy is necessary to distinguish between cases of 
high admission serum creatinine due to chronic renal 
disease and high creatinine due to some acute injury3. 
specific evaluation and allocation is necessary for 
marginal grafts with possible chronic lesions before 
considering them for transplantation.
in 2001, a concensus meeting of the American 
society of transplantation and American society of 
transplant surgeons was held in Crystal City, Virginia. 
The goal of the meeting was development of guidelines 
for improving recovery and transplantation of organs 
from deceased donor. The Kidney work group dis-
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cussed how to increase the use of older donor kidneys, 
decrease cold ischemia time and delay graft function. 
in this way, patient outcome could be improved, as it 
could decrease hospital stay and costs14.
in order not to discard kidneys from eCd, but 
improve their allocation and graft survival, nyberg et 
al. developed a scoring system for these kidneys. de-
ceased donor score (dds) includes scores for donor’s 
age, hypertension, creatinine clearance, hlA mis-
match and cause of death. if the score is higher than 
20, 6-year graft survival is lower than 70%; if dds 
score is lower than 20, 6-year graft survival is higher 
than 80%15. 
Dual Kidney Transplantation 
transplantation of dual eCd kidneys represents 
one of the possible ways to reduce number of discard-
ed kidneys and increase nephron mass of “marginal” 
kidneys. it may be a good approach in expanding the 
donor pool. still, there are no determined criteria for 
single or dual transplantation in a recipient of eCd 
kidney. 
one of the first reports of dual kidney transplanta-
tions from older donors showed that these recipients 
had decreased incidence of delayed graft function, 
better graft function and survival than recipients of 
single kidney from similar age donors16. some stud-
ies praise strategy of dual kidney transplantation in 
expanding the donor pool, but found a high incidence 
of primary nonfunction17,18.
in 2003, Bunnapradist et al. showed similar out-
come of 403 dual transplantations (mean donor age 
60.8 years) with 11033 single kidney transplantations 
when recipients of single kidney were grafted with do-
nors aged over 55 years19.
in 1999, Remuzzi et al. compared graft survival of 
single and dual kidney transplants from eCd (donor 
age >60, history of diabetes or hypertension, urine 
protein excretion up to 3 g/24 h) based on clinical 
or preimplantation histologic evaluation. This study 
showed that graft evaluated histologically before im-
plantation had similar outcome in dual transplant 
recipients as single grafted recipients from younger 
donors. These results strongly suggest that histologic 
criteria should be considered as an important part on 
choosing between single and dual kidney transplanta-
tion from marginal donor20. 
Recipient Selection and Immunosuppression
it is important to mention that long-term graft and 
patient survival after transplantation has improved in 
the last years, as a result of factors like good patient 
care, enhanced organ preservation and surgical tech-
niques, effective antimicrobial prophylaxis and avail-
ability of potent immunosuppression regimens21. one 
possible additive factor may be proper selection of re-
cipients for certain graft. 
elderly patients make up an increasing percent of 
the waitlist, as well as of donated and recovered kid-
neys. The use of older donors for kidney transplan-
tation may create obstacles to long-term survival, as 
older kidneys are associated with inferior outcomes. 
however, the major risk for dialysis patients is to stay 
on dialysis, thus elderly patients should be individu-
ally evaluated for renal transplantation. ‘physiologic’ 
age is much more important than ‘chronologic’ age in 
this group of patients22.
stratta et al. studied 90 recipients of adult donor 
kidneys transplanted from 2001 to 2003 (37 from 
eCds and 53 from sCds). Recipient selection for 
marginal kidney was based on their estimated need 
for nephron mass by using the criteria of age >40 
years, low body mass index (<25 kg/m2), and low im-
munologic risk (first transplantation, 0% pRA, hlA 
matching). They conclude that eCd kidneys should 
be used for carefully selected patients, with the use 
of ‘nephron sparing strategy’. it means that long-cold 
ischemia time should be avoided, as well as nephro-
toxic immunosuppressive protocols23. severe donor-
recipient size mismatching should be avoided.
The eurotransplant senior program (esp) al-
locates kidneys from older donors to recipients older 
than 65 years. This program has significantly in-
creased the number of transplantations performed in 
elderly patients. Croatia has introduced its own ‘se-
nior’ program in 2005, based on esp but with hlA 
matching, which improved outcomes compared to 
eurotransplant results24. Currently, elderly patients 
wait for less than 6 months to receive transplant in 
Croatia.
while kidneys from eCd are supposed to have 
already suffered injury, any further damage should be 
avoided. stratta et al. have presented the management 
protocol for eCd kidneys. it is based on the number 
of nephron sparing maneuvers by minimizing cold 
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ischemia time, pulsatile perfusion preservation, immu-
nosuppression with depletion antibodies to minimize 
preservation injury and risk of rejection, delayed cal-
cineurin administration and lower tacrolimus levels to 
maintain balance between effectiveness and toxicity23. 
nephrotoxic immunosuppressive protocols should 
be avoided, which means delayed introduction of cal-
cineurin inhibitors under the umbrella of antibod-
ies (either monoclonal in patients with low immune 
risk, or polyclonal in patients with high immune 
risk). Based on our experience, these protocols are 
safe and are not associated with increased incidence 
of acute rejections. mammalian target of rapamycin 
inhibitors (mtoR) seems promising in this setting. 
Three preliminary reports suggest that calcineurin 
inhibitor-free protocols with costimulation blockade 
in recipients from eCd decrease the incidence of de-
layed graft function, but further studies have to con-
firm this. Thus, novel immunosuppressive drugs may 
contribute to less nephrotoxic protocols25. however, 
current protocols recommend their use after at least 
one month of transplantation to avoid problems with 
wound healing.
Conclusion
Kidney donor pool has evolved over the last few 
years mainly due to the utilization of eCd. however, 
recipients of kidneys from eCd have by definition 
inferior graft and worse overall survival. potential 
recipient has to be well informed about the risks of 
transplanting grafts from eCd. such grafts are not 
for ‘expanded recipient criteria’, but for recipients with 
low risks and demands. to find the best donor-recipi-
ent match, specific allocation policies are required. A 
challenge is to minimize transplantation outcome dif-
ferences between grafts from sCd and eCd. 
References
1. wolfe RA, AshBy VB, milfoRd el, et al. Compari-
son of mortality in all patients on dialysis awaiting transplan-
tation, and recipients of a first cadaveric transplant. n engl J 
med 1999;341:1725-30.
2. oJo Ao, hAnson JA, meieR-KRiesChe h, et al. 
survival in recipients of marginal cadaveric donor kidneys 
compared with other recipients and wait-listed transplant 
candidates. J Am soc nephrol 2001;12:589-97.
3. dAhmAne d, AudARd V, hiesse C, et al. Retrospec-
tive follow-up of transplantation of kidneys from ‘marginal’ 
donors. Kidney int 2006;69:546-52.
  4. poRt fK, BRAgg-gReshAm Jl, metZgeR RA, et 
al. donor characteristics associated with reduced graft sur-
vival: an approach to expanding the pool of kidney donors. 
transplantation 2002;74:1281-6.
  5. metZgeR RA, delmoniCo fl, feng s, et al. 
expanded criteria donors for kidney transplantation. Am J 
transplant 2003;3(suppl 4):114-25.
  6. mAssie AB, stewARt de, dAgheR nn, mont-
gomeRy RA, desAi nm, segeV dl. Center-level 
patterns of indicated willingness to and actual acceptance of 
marginal kidneys. Am J transplant 2010;10:2472-80.
  7. osteRmAnn m, ChAng Rw. Acute kidney injury 
in the intensive care unit according to Rifle. Crit Care 
2007;35:1837-43.
  8. Kes p, BAšić JuKić n. Acute kidney injury in the inten-
sive care unit. Bosn J Basic med sci 2010;10(suppl 1):s8-12. 
  9. Kes p, BAšić JuKić n. new experiences with the therapy 
of acute kidney injury. prilozi 2008;29(2):119-53. 
10. moRgAn C, mARtin A, shApiRo R, et al. outcomes 
after transplantation of deceased-donor kidneys with rising 
serum creatinine. Am J transplant 2007;7:1288-92.
11. RodRigo e, minAmBRes e, pineRA C, et al. us-
ing Rifle criteria to evaluate acute kidney injury in 
brain deceased kidney donors. nephrol dial transplant 
2010;25(5):1531-7.
12. Anil KumAR ms, KhAn sm, JAglAn s, et al. suc-
cessful transplantation of kidneys from deceased donors 
with acute renal failure: three year results. transplantation 
2006;82:1640-5.
13. RemuZZi g, CRAVedi p, peRnA A, et al. long-term 
outcome of renal transplantation from older donors. n engl J 
med 2006;354:343-52.
14. RosengARd BR, feng s, AlfRey eJ, et al. Report of 
the Crystal City meeting to maximize the use of organs recov-
ered from the cadaver donor. Am J transplant 2002;2:701-11.
15. nyBeRg sl, mAtAs AJ, KRemeRs wK, et al. im-
proved scoring system to assess adult donors for cadaver renal 
transplantation. Am J transplant 2003;3:715-21.
16. lu Ad, CARteR Jt, weinstein RJ, et al. excellent 
outcome in recipients of dual kidney transplants: a report of 
the first 50 dual kidney transplants at stanford university. 
Arch surg 1999;134:971-5 discussion 975-6.
17. tAn JC, AlfRey eJ, dAfoe dC, et al. dual kidney 
transplantation with organs from expanded criteria donors: a 
long-term follow-up. transplantation 2004;78:692-6.
18. AlfRey eJ, Boissy AR, leRneR sm, et al. dual-kid-
ney transplants: long-term results. transplantation 2003;75: 
1232-6.
19. BunnApRAdist s, gRitsCh hA, peng A, et al. 
dual kidneys from marginal donors as a source for cadaveric 
228 Acta Clin Croat,  Vol. 52,   No. 2,  2013
iva Bačak Kocman et al. Kidney transplantation from deceased donors with high terminal serum creatinine
renal transplantation in the united states. J Am soc nephrol 
2003;14:1031-6.
20. RemuZZi g, gRinyo J, Ruggenenti p, et al. early 
experience with dual kidney transplantation in adults using 
expanded donor criteria. double Kidney transplant group 
(dKg). J Am soc nephrol 1999;10:2591-8.
21. seRuR d, sAAl s, wAng J, et al. deceased-donor kidney 
transplantation: improvement in long-term survival. nephrol 
dial transplant 2011;26:317-24.
22. BAsiC-JuKiC n, Kes p. Renal transplantation in the el-
derly. nephrol dial transplant 2012;27(3):1267-8.
sažetak
tRAnsplAntACiJA BuBRegA od  pReminulih dARiVAtelJA s poVišenom ZAdnJom 
VRiJednosti  KReAtininA
I. Bačak Kocman, L. Katalinić, Ž. Kaštelan, P. Kes, I. Kocman, E. Goluža, M. Perić i N. Bašić Jukić 
ukupni broj darivatelja organa u posljednje je vrijeme nepromijenjen, a sve veći broj potencijalnih primatelja bubrega 
na listi čekanja doveo je do razvoja novih strategija i proširenja kriterija kojima se procjenjuje mogući darivatelj organa. 
prije se smatralo da su bubrezi darivatelja po proširenim kriterijima lošiji zbog veće učestalosti oštećenja tijekom konzer-
viranja bubrega, češće odgođene funkcije presatka, odbacivanja i primarne afunkcije organa. danas je mnogim velikim 
transplantacijskim centrima cilj smanjenje razlike u ishodu presatka transplantiranog s darivatelja po proširenim kriteri-
jima i darivatelja po standardnim kriterijima. ovaj cilj uključuje strogu kontrolu u skraćivanju vremena hladne ishemi-
je, odabira primatelja, prilagođene protokole imunosupresije, povećanje mase nefrona s transplantacijom “dva u jedan” i 
primjenu histoloških kriterija u odabiru grafta marginalnog darivatelja. Zasad nema mnogo objavljenih radova o ishodu 
transplantiranog bubrega darivatelja s akutnim zatajenjem bubrega ili visokom zadnjom vrijednosti kreatinina u serumu. 
namjera ovoga preglednog članka je prikazati najnoviju definiciju marginalnog darivatelja i darivatelja s akutnim zataje-
njem bubrega. primatelji bubrega darivatelja po proširenim kriterijima moraju tijekom prijetransplantacijske obrade biti 
dobro obaviješteni o svim mogućnostima i komplikacijama takvog postupka, te potpisati obaviješteni pristanak. poznate 
studije pokazale su da se pod strogo kontroliranim kriterijima bubrezi darivatelja po proširenim kriterijima mogu sigurno 
transplantirati odabranim primateljima, s dobrim kratkoročnim i dugoročnim ishodom.
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